Longevity Science

Lp(a): The Genetic Heart Risk You’ve Never Heard Of

While LDL cholesterol is the traditional focus of cardiovascular health, Lipoprotein(a) represents a silent, genetically determined risk factor that affects 1 in 5 people globally—and standard lifestyle changes rarely move the needle.

By Dr. Kurt Hong MD | February 14, 2026

Lipoprotein(a), often referred to as Lp(a), is a particle in your blood that carries cholesterol, similar to LDL (the "bad" cholesterol). However, Lp(a) is uniquely dangerous. Because of its sticky nature and the presence of a specific protein called apolipoprotein(a), it is highly prone to causing plaque buildup and blood clots in the arteries.

Understanding the Genetic Blueprint

Unlike LDL cholesterol, which is heavily influenced by diet, exercise, and lifestyle, your Lp(a) levels are almost entirely determined by your genetics. You are born with a specific level that remains relatively constant throughout your life. This means that even the most disciplined athlete or vegan can harbor dangerously high levels of this cardiovascular toxin.

Why Testing is Critical

Standard lipid panels do not include Lp(a) testing.
It is a major driver of "unexplained" heart attacks in healthy individuals.
High levels triple the risk of coronary artery disease.
Identifying risk early allows for aggressive management of other factors (ApoB, Blood Pressure).

20%

Global Prevalence

>50

High mg/dL Threshold

CAD Risk Multiplier

"Lp(a) is the missing link in cardiovascular screening. We can no longer ignore the 20% of the population who are genetically predisposed to early heart disease."

Key Insights

Current statin therapy effectively lowers LDL but has little to no impact on Lp(a) levels. In some cases, statins may even slightly increase Lp(a), making accurate baseline testing even more vital.

Did You Know?

Clinical trials are currently underway for antisense oligonucleotides (ASOs) that can lower Lp(a) by up to 80-90%. We are on the cusp of the first direct pharmacological intervention for this risk factor.

Risk Levels

Lab Value (mg/dL)

Risk Classification

< 30

Normal / Low Risk

30 – 50

Borderline Risk

50 – 125

High Clinical Risk

> 125

Very High Risk

Your Action Plan

Get tested: Ask specifically for an Lp(a) mass or molar concentration test.
Check Family History: Early heart disease in relatives is a red flag.
Manage Comordinities: Aggressively target BP and ApoB levels.

References

Tsimikas S. A Test in Context: Lipoprotein(a). J Am Coll Cardiol. 2017;69(6):692-711.
Virani SS, et al. Heart Disease and Stroke Statistics—2021 Update. Circulation. 2021;143:e254–e743.
Kronenberg F, et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis. Eur Heart J. 2022.